Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent.
about
Small Molecular TRAIL Inducer ONC201 Induces Death in Lung Cancer Cells: A Preclinical Study.AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms.Cell sources for in vitro human liver cell culture models.Lipid-based nanovesicles for nanomedicine.Kaempferol induces autophagic cell death of hepatocellular carcinoma cells via activating AMPK signaling.
P2860
Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Preclinical Evaluation of Lipo ...... epatocellular Carcinoma Agent.
@ast
Preclinical Evaluation of Lipo ...... epatocellular Carcinoma Agent.
@en
type
label
Preclinical Evaluation of Lipo ...... epatocellular Carcinoma Agent.
@ast
Preclinical Evaluation of Lipo ...... epatocellular Carcinoma Agent.
@en
prefLabel
Preclinical Evaluation of Lipo ...... epatocellular Carcinoma Agent.
@ast
Preclinical Evaluation of Lipo ...... epatocellular Carcinoma Agent.
@en
P2093
P2860
P1433
P1476
Preclinical Evaluation of Lipo ...... epatocellular Carcinoma Agent.
@en
P2093
Chenglin Li
Huiqing Lv
Weihong Gong
Yaoxia Wang
Zhongmin Zhang
P2860
P304
P356
10.1371/JOURNAL.PONE.0145195
P407
P577
2016-01-04T00:00:00Z